NKTR Nektar Therapeutics

NASDAQ
$46.99

Nektar Therapeutics (NKTR) SEC Filings

Everything NKTR has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

56 filings
Date Form Filing
8-K
SCHEDULE 13G/A
4
4
4
4
4
8-K Other · Other Event
8-K Other Reg Fd · Reg Fd
4
4
10-Q
4
4
4
4
4
4
4
10-Q
10-K
4
4
4
4
4
4
4
4
10-Q
4
4
4
4
4
4
4
4
4
4
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.